Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria R De Filippo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pathology|November 24, 2015
Uterine adenosarcomas are mesenchymal neoplasmsSalvatore Piscuoglio, Kathleen A Burke, Charlotte K Y Ng, et al.
The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.
The Journal of Pathology|May 27, 2015
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyElena Guerini-Rocco, Zsolt Hodi, Salvatore Piscuoglio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 6, 2016
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerNicola Fusco, Felipe C Geyer, Maria R De Filippo, et al.
The Journal of Pathology|June 23, 2015
Genomic landscape of adenoid cystic carcinoma of the breastLuciano G Martelotto, Maria R De Filippo, Charlotte K Y Ng, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Oncotarget|May 15, 2018
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastasesLeticia De Mattos-Arruda, Charlotte K Y Ng, Salvatore Piscuoglio, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature Communications|February 19, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancerSofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Pathology|November 24, 2015
Uterine adenosarcomas are mesenchymal neoplasmsSalvatore Piscuoglio, Kathleen A Burke, Charlotte K Y Ng, et al.
The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.
The Journal of Pathology|May 27, 2015
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating studyElena Guerini-Rocco, Zsolt Hodi, Salvatore Piscuoglio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 6, 2016
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerNicola Fusco, Felipe C Geyer, Maria R De Filippo, et al.
The Journal of Pathology|June 23, 2015
Genomic landscape of adenoid cystic carcinoma of the breastLuciano G Martelotto, Maria R De Filippo, Charlotte K Y Ng, et al.
Nature|July 17, 2019
Author Correction: Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Oncotarget|May 15, 2018
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastasesLeticia De Mattos-Arruda, Charlotte K Y Ng, Salvatore Piscuoglio, et al.
Nature|May 24, 2019
Genomic characterization of metastatic breast cancersFrançois Bertucci, Charlotte K Y Ng, Anne Patsouris, et al.
Nature Communications|February 19, 2021
Patient-derived xenografts and organoids model therapy response in prostate cancerSofia Karkampouna, Federico La Manna, Andrej Benjak, et al.
The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Pageof 2